sarcopenia, frailty, fracture, cerebral infarction
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients who are 65 years old or older and who are admitted to the Recovery Rehabilitation Ward (2) Subjects who have decreased muscle mass or grip strength (3) Subjects who can take oral intake
Exclusion criteria
Exclusion criteria: (1) Subjects with serious heart disease, renal disease, or liver disease (2) Those who are using steroids (3) Individuals who have difficulty observing and evaluating dietary guidance due to dementia, mental illness, etc. (4) Those who have implanted cardiac pacemakers or implanted cardioverter-defibrillators (5) Individuals who are deemed inappropriate for this clinical study by the research implementation supervisor or research co-investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in muscle mass, strength and physical function over 2 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in stratum corneum water content, changes in skin elasticity, and changes in blood test results (hemoglobin, aspartate aminotransferase, alanine aminotransferase, creatinine, blood urea nitrogen, estimate glomerular filtration rate, serum albumin, C-reactive protein, rapid turnover protein) over the 2 months | — |
Countries
Japan
Contacts
Kansai Electric Power Hospital Center for Metabolism and Clinical Nutrition